
Scientists have developed a new method called 'liquid biopsy' to detect brain cancer. This method is faster and more accurate than the traditional surgical biopsy. Liquid biopsy requires only 100 microliters of blood, which means the test can be done with just a drop of blood. This method can detect biomarkers associated with glioblastoma (the most aggressive type of brain tumor) in just 60 minutes.
A team of researchers from the University of Notre Dame in America, along with Australian scientists, developed this new method. The research, published in the journal Communications Biology, states that this method is more accurate than any other known method for detecting glioblastoma. Clinical tests were conducted on 20 glioblastoma patients and 10 healthy individuals, and the results were quite promising. This is a significant step forward in the diagnosis of brain cancer.
Researchers say that after diagnosis, glioblastoma patients typically live for 12-18 months. Usually, surgical biopsy is used to detect this aggressive cancer, which is a difficult and time-consuming process. The new method uses electrokinetic technology to detect biomarkers or active epidermal growth factor receptors (EGFR).
The new method uses a special biochip to detect EGFR. The chip costs less than two dollars (approximately 167 rupees) and has a small sensor the size of a ballpoint pen tip. When a blood sample is applied to the biochip, the voltage in the plasma solution changes, creating a high negative charge, which indicates the presence of cancer.
Updated on:
26 Sept 2024 04:25 pm
Published on:
26 Sept 2024 01:43 am
Big News
View AllHealth
Trending
Lifestyle
